Hematology/Oncology News

Bypassing the blood-brain barrier remains an obstacle for novel therapeutics. Healio spoke to Thomas Chen, MD, PhD, founder and CEO of NeOnc, to find out how a novel nasal spray formulation to treat brain cancer overcomes these challenges.

The FDA approved the novel immunotherapy denileukin diftitox-cxdl for treatment of certain patients with relapsed or refractory cutaneous T-cell lymphoma.

More than 16% of Americans live at least a 4-hour drive from the closest proton beam therapy facility, according to data published in JAMA Network Open.

U.S. cancer centers often ask patients about smoking status, but results of an online survey revealed critical gaps in efforts to help patients quit.

I've been in the pursuit of becoming a physician ever since I can remember.

Individuals with cannabis-related disorder exhibited increased risk for head and neck cancer, results of a retrospective cohort study showed.

In this special throwback episode, Shikha Jain, MD, talks with Olympic champion Kikkan “Kikkanimal” Randall, about how her positive attitude and athlete mentality have helped her navigate a breast cancer diagnosis and treatment, valuable advice for both oncologists and patients and more.

The addition of an investigational cancer vaccine to pembrolizumab failed to improve outcomes for patients with metastatic or recurrent head and neck squamous cell carcinoma, according to the agent’s manufacturer.

On June 28, the U.S. Supreme Court ruled 6-3 in Loper Bright Enterprises v. Raimondo, Secretary of Commerce to overturn a decades-old decision known as the “Chevron deference.”

Older patients who had a primary care visit within 90 days after cancer surgery exhibited significantly reduced mortality risk, according to retrospective study results.